Ambulation for patients with total body involved cerebral palsy poses greater problems than those encountered in providing reciprocal walking for thoracic lesion paraplegic subjects.
Introduction
Since the 1970s there has been a major international effort in making effective walking systems available to paralysed children and adults (Douglas et al, 1983; Motloch and Elliot, 1966; Rose and Henshaw, 1972; Butler et al, 1982; Kirtley, 1992; Lissons, 1992; Butler and Major, 1987) . The objectives for this have been widely stated as: to provide therapeutic benefit; to achieve improved independence; to enhance psychological outlook. Success in achieving these objectives has been reported anecdotally by Rose (1976) and Menelaus (1987) amongst others, and verified scientifically by Mazur et al. (1989) .
Whereas, during the period of those developments, the incidence of many congenital or neonatal pathologies which predispose to paraplegia has been decreasing, cerebral palsy has remained consistent at 3.5 per 1,000 live births (Pharoah et al., 1990) . Since survival rates of cerebral palsy patients are now increasing sharply (Alberman and Botting, 1991) ever greater numbers of those who are severely disabled are presenting at orthopaedic clinics. Whilst they share many of the difficulties of the paraplegic community, they have the added problems of a lack of truncal and upper limb control. Until recently this has prevented them from taking advantage of the technological developments which have been applied in paraplegic walking, and the concomitant therapeutic benefits. The forces and moments generated by inappropriate muscle action in all parts of the body contribute to the difficulty of using existing systems to permit ambulation.
Building on the fundamental principles of paraplegic walking developed by ORLAU (Stallard et al, 1986; Stallard et al, 1989 ) a system has been evolved which for the first time led to a means of walking for severely disabled cerebral palsy patients (Thompson and Patrick, 1990; Stallard et al, 1996) . Whilst this concept system (called the Locomotor Guidance System, (Fig. 1) ) allowed a number of patients to walk in a household environment and gave great satisfaction to the children and their parents, it quickly became apparent that the walking frame developed by ORLAU as part of the system had fundamental limitations. In particular: (a) it did not provide sufficient postural control; (b)the vertical support was indeterminable and this limited the potential for effective reciprocation in many patients; (c) the patient's hands were required to grip the walking frame which prevented other activities; (d)the system was rarely used for outdoor walking. The Locomotor Guidance System (LGS) showed that it was possible, using suitably modified orthotic technology originally intended for paraplegic walking, to achieve ambulation by providing an appropriate degree of directional control of the lower limbs in patients who generated severe aberrant abduction/adduction moments and rotational torque about the longitudinal axis at the hip joint. Identification of the fundamental limitations of the associated ORLAU walking frame when used with the particular target group provided a basis for investigating the availability of devices which could address those limitations. Such information is not readily available and a review of walking frames from a variety of sources was therefore limited.
Walking frame review
To permit as comprehensive a review of potential systems as possible two complementary exercises were undertaken: (a) consultation with professional colleagues; (b) review of publicly available information.
These confirmed that a small amount of work had been undertaken to address some of the identified requirements. In particular patents had been filed by Motloch (1980) and Hart (1990) on walking frames which provided vertical support via a truncal location attached to a sprung arm articulated on a stanchion mounted to the rear of a wheeled frame which surrounds the patient.
Discussions with Motloch indicated that he had permitted his patent to lapse because he was unable economically to justify a challenge to a commercial company who were planning to exploit similar ideas. He agreed to sell the remaining stock of his prototype to ORLAU for clinical evaluation. In a further co-operative gesture he revealed the source of a commercially available device (the Mulholland Walkabout) which employed similar principles to those included in his patent. Figure 2 shows the latter device which incorporates the essential principles of such walking frames.
A copy of the Hart (1990) patent was obtained which revealed similar thinking with regard to patient support but included a unique steering mechanism, the practical utility of which would not be relevant to the patients being treated by ORLAU because of their inability to produce controlled side thrust in the lower limbs.
The information provided by Motloch enabled a commercial supply of a Rear Support Walking Frame to be obtained from the manufacturer (Mulholland) for evaluation.
Thorough examination of the two patents and the Motloch prototype suggested that they would be likely to permit an important step forward by providing some of the features which the earlier work on the Locomotor Guidance System (LGS) (Stallard et al., 1996) had shown was necessary.
Concept development
The target group of patient for the project was total body involved cerebral palsy patients who were at least 8 years old and with a body weight of approximately 25kg or greater.
Early laboratory experimental work with the Motloch Prototype Rear Support Walking Frame on patients whose parents had given informed consent showed by visual observation of video recordings that a more vertical postural alignment of the trunk was maintained than was possible with the existing ORLAU Walking Frame. This experimental experience suggested very strongly that total body involved cerebral palsy patients using a Variable Specification Orthosis (Stallard et al, 1996) (Fig. 3 ) for ambulation purposes would be able to extend their activities beyond the indoor walking to which is was necessary to restrict them when using the ORLAU Walking Frame Following the encouraging experience with the Motloch device the Mulholland Walkabout was also obtained for laboratory trials. This achieved similar results and reinforced the confidence that the principle of a rear support walking frame was potentially a positive approach in achieving improved ambulation performance for severely disabled cerebral palsy patients.
Detailed analysis of the laboratory experience of the two walking frames (and further study of the published patents) showed that whilst the principles of the design of such devices provided a good basis for progress each had some or all of the following problems when used with the target group: (a) the means of providing patient support did not permit easy fine control and could not be set to specified levels. Any adjustment whilst the patient was using the system was very haphazard and could be counter-productive; (b) the magnitude of support was insufficient for some patients in the target group; (c) location of patient to the walking frame was suitable only for use without a control orthosis;
(d) stiffness of the walking frame was insufficient to maintain the necessary postural alignment for patients in the target group; (e) there was insufficient stability for many patients in the target group. Subsequent development has therefore been undertaken to explore still further the issues which need to be addressed.
Prototype development
The basic framework of the Mulholland Walkabout was considered to be suitable for examining issues of:
the necessary degree of accuracy of patient vertical support; the means of making support more easily adjustable; the reaction of patients to using a walking frame which controlled truncal posture and vertical support more accurately and consistently. Modifications were incorporated to provide more consistent and easily adjustable vertical support by replacing the variable spring mechanism, through which the rear support pantograph structure was suspended, with gas struts (the devices used to support the tailgate of family cars). The load in these can be varied by releasing the gas pressure and this allows sensitive adjustment of vertical force when used in combination with the variety of hole positions on the pantograph supplied as standard on the Mulholland Walkabout.
All of the patients for whom the new walking frame was intended required control of their lower limbs. They therefore had the Variable Specification Orthosis (Stallard et al, 1996) supplied as part of the overall system. A feature of that orthosis is that it has two transverse rigid tubes making up the body brace section. In order to locate the patient to the walking frame a hook to accommodate the lower tube and a clamping plate for the upper tube of the orthosis were mounted on the front stay of the Mulholland pantograph Early experimental work showed that patients of 25kg or above caused sufficient flexibility in the structure with the vertical support set at the levels commonly required by the target group to cause malalignment of truncal posture. To reduce this problem the rear stanchion rectangular hollow tube was replaced with one 
Patient trials
Following laboratory test work and refinement of the prototype system based on the modified Mulholland Walkabout four neurologically impaired patients having severe walking disability were selected to use the system at home and/or school. All were keen to ambulate and were judged by a physiotherapist with experience in supplying the original ORLAU LGS ( Thompson and Patrick, 1990) to be equivalent in terms of function to those previously supplied. Each had ambitions to walk in a wider context than was possible with the original ORLAU walking frame, which had restricted patients to indoor use only.
The new system was explained in detail and the experimental nature of the work was revealed to all concerned. Patient and parental consent to proceed was obtained.
A Variable Specification Orthosis (Stallard et al., 1996) was produced and a Mulholland Walkabout acquired for each of the patients. The previously detailed modifications were made to the Walkabout prior to supply. Individual fitting and training sessions were arranged and when necessary repeat sessions were organised. During the training assessments were made regarding the degree of vertical support required on an individual basis. At the completion of fitting and training patients were allowed to take the system home or to their school and 3 month follow-up appointments were made to enable their progress in achieving ambulation in a wide variety of environments to be monitored.
Results
Patient details and the environments in which they were able to use the modified Mulholland Rear Support Walking frame and Control Orthosis (LGS) are shown in Table 1 . A manifestation of the complete system being used in a typical fashion is shown in Figure 5 .
None of the patients had previously been able to walk without carer support. All of the patients were able to walk without carer support when using the LGS.
The optimal vertical support from the Rear Support Walking Frame identified for each patient, as a proportion of body weight was significantly different in each patient and varied from 37% to 81%. Three of the patients were able to walk up to 400m (or beyond) each day, and the time they were in the system varied from 30 minutes to more than 4 hours -the average time being approximately 1.8 hours on each day they walked. Daily usage varied from 3 to 5 days per week. When using the new Rear Support Walking Frame system only one of the four patients was unable significantly to extend beyond the purely indoor home or school environment the remainder were able to walk on a variety of surfaces including grass and country pathways. This was not only an important achievement for them personally but the family unit in which they lived were able to extend the range of their leisure activities. In one case the family made the unsolicited comment that when using the system they found other people, for the first time, approaching their child to strike up a conversation. A teacher at a school attended by a different patient made the comment that the child was able independently, for the first time, to explore the outdoor environment (Parry, 1993) . In the other case where the system was used outdoors for country walks the mother expressed her pleasure at being able to hold her child's hand whilst walking, which she considered an important element of family bonding which had previously been denied them.
Discussion
The results of the development work in producing a modified rear support walking frame to broaden the scope of walking environments for severely disabled cerebral palsy patients were encouraging. Three out of the four patients greatly increased the range of ambulation activities in comparison with 14 patients of the same category who had previously been supplied with the original Locomotor Guidance System, which had restricted all of them to indoor use only (Stallard et ah, 1996) . It became clear that the new Walking Frame had much more potential for producing viable walking for the target group than the more conventional ORLAU Walking Frame used previously by patients prescribed with the ORLAU LGS. The length of time for which the patients were content to use the system was considered an important factor. An average use of 1.8 hours on each occasion is sufficiently long to permit beneficial therapeutic effects to occur.
The optimal level of vertical support showed a very wide variation (37 to 81% body weight). This reflects the sensitivity of this parameter in determining the ability of patients to walk effectively. Experience in the earlier system with anterior support walking frame (Stallard, 1996) had suggested this was likely to be the case. However, the degree of accuracy to which this parameter needed to be set was greater than anticipated. Variations of as little as 10% had a profound effect on walking performance in some of the patients.
The work undertaken not only provided encouragement for the general approach which had been adopted, but also identified important factors which need further attention before such a system can be considered a fully practical option. In particular the following were recognised as areas which will demand more development: (a) transfer of the patient into the walking frame required more care assistants than it would normally be practical to provide. In every case at least two adults were necessary and sometimes three were involved in the transfer process; (b) the optimal level of vertical support for the patients using the trial devices was even more sensitive than previous experience had suggested would be the case. Alterations of less than 10% could produce noticeable changes in an ability to make forward progression. The incremental changes to vertical support made available on the trial walking frames was greater than the sensitivity identified as being required. Continuously variable vertical support which can be changed with the patient in the system would be a great advantage in overcoming that difficulty. It is thought that the degree of optimal support should be in the range 20 to 80% of patient body weight; (c) the rigidity of the structure, despite being modified to decrease flexibility, was still insufficient to inhibit truncal malalignment to an optimal degree. Further analysis of the specific structural performance is necessary to ensure that the design can be configured to enable heavier patients to maintain good truncal posture at all stages of ambulation; (d) steering on the walking frames provided was by front castor wheels only. All of the patients in the trial found it difficult to control direction with this arrangement because of their inability to produce controlled side thrust with their lower limbs. It is clear that further work on steering is necessary for patients in the target group in order to produce solutions not available with any existing devices;
(e) transportability was not sufficiently convenient for many families, the overall weight being too high and the size of the modules being rather large; (f) the aberrant uncontrolled movements of some patients made it necessary to improve stability by placing ballast low down on the walking frame structure. Whilst this made ambulation a practical proposition for the patient, it increased the inconvenience to parents of transporting the system. A more acceptable means of coping with the stability requirements of some is desirable. Anecdotal comments from the parents or carers have been included in the description of the trial of the system because they illuminate the progress which the development has made. Only the teachers comments are formally referenced in order to protect the anonymity of the families involved in the trial.
Experience with the earlier "household" LGS marketed by R. Taylor & Son Ltd. showed that a walking frame which provides the control necessary within the LGS has a much wider application for patients who do not need the high level of orthotic control provided by the orthosis element of the ORLAU System. Between ten and twenty times the number of the ORLAU Walking Frame were sold than LGS treatment systems were provided. This underlines the wide potential market which exists for an effective Walking Frame with the essential elements required as part of the less widely needed LGS. This was instrumental in gaining commercial support for further development.
Conclusion
Initial development work has shown that the use of a rear support walking frame which provides sensitive control of vertical support can produce improvements in the effectiveness of ambulation for severely disabled children with cerebral palsy. There is clearly a need for further fundamental work before production development of an improved system can be undertaken. A proposal has been made to the UK DH MedLINK Programme to study the areas which have been identified as requiring further investigation. This has been successful and work has now commenced on a study of the problems identified in the preliminary trial in collaboration with Remploy Ltd. and Carbon Concepts Ltd. possible to make progress.
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